Inhaled corticosteroid/long-acting beta-agonist combination therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Inhaled corticosteroid/long-acting beta-agonist combination therapy, covering 2025-09-17 to 2025-09-17. Get the full timeline:
Most recent: Clinical Trial Update: Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers [Phase 1, Phase 2]